| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc. | Parsons James T. | Director | Jan 03, 2022 | Option Exercise | $3.58 | 16,773 | 60,047 | 38,509 | Jan 03, 2022, 04:21 PM | |
| TRIL | Trillium Therapeutics Inc. | Parsons James T. | Chief Financial Officer | Jan 08, 2021 | Option Exercise | $11.52 | 17,010 | 195,887 | 8,505 | Jan 12, 2021, 04:12 PM | |
| DMAC | DiaMedica Therapeutics Inc. | Parsons James T. | Director | Jan 01, 2021 | Option Exercise | $8.23 | 7,745 | 63,741 | 21,947 | Jan 04, 2021, 04:21 PM | |
| DMAC | DiaMedica Therapeutics Inc. | Parsons James T. | Director | Jun 01, 2020 | Option Exercise | $4.59 | 8,102 | 37,188 | 14,202 | Jun 02, 2020, 04:49 PM | |
| DMAC | DiaMedica Therapeutics Inc. | Parsons James T. | Director | Dec 11, 2018 | Buy | $4.00 | 2,250 | 9,000 | 6,100 | Dec 11, 2018, 04:27 PM |
Menu